Project management and Business development at SAARUM sciences specialized in pre-clinical Drug discovery
Industry
Medical / Health Care / Pharmaceuticals
About
Average cost of bringing new drug to market is approximately $2 billion which is way higher than the cost of round trip to moon. A recent detailed investigation on origin of newly approved drugs, revealed the prominence of phenotypic approach in discovery of first in class small molecules. Which strengthens the role of disease relevant in vitro assays in success of clinical outcome.
We at SAARUM provide a screening platform with patient derived clinically relevant cells for small molecule drug discovery, biomarker discovery, phenotypic screening, target identification and validation, bio similar, Bio better screening, studies for drug re-purposing etc.
Also, specific patient population...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
